T-NON-HODGKIN LYMPHOMA
Clinical trials for T-NON-HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-NON-HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for T-NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take aim at tough T-Cell cancers
Disease control Recruiting nowThis early-phase trial tests a new approach for people with certain T-cell blood cancers (leukemia or lymphoma) that have returned. Researchers take a patient's own immune cells (or cells from a past stem cell donor), add a special receptor that targets a protein called CD5 found…
Matched conditions: T-NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
Engineered donor cells take aim at tough T-Cell cancers
Disease control Recruiting nowThis early-phase study tests a new treatment for people with T-cell leukemia or lymphoma that has come back. The treatment uses specially trained immune cells from a healthy donor, designed to recognize and attack cancer cells carrying a marker called CD7. The goal is to see if t…
Matched conditions: T-NON-HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC